Serum Institute Resumes Export Of Covishield Vaccine
The Serum Institute of India (SII) On November 26 resumed the export of Covishield, a made-in-India vaccine against Covid-19. The export service has been resumed under the global vaccine sharing programme namely 'COVAX', reported PTI. ''The first batches of the vaccine left the SII manufacturing facility in Pune,'' said the company. So far, the SII produced close to 1.25 billion vaccine doses.